Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

CPRIT Awards Pulmotect $7.1 Million to Develop Novel Immune Stimulant

Posted on March 29, 2017March 31, 2017 by admin
Posted in Press Releases

Post navigation

Texas Emerging Technology Fund Makes Investment in Pulmotect
Pulmotect Wins Southeast BIO Early Stage Shootout
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2022
Pulmotect, Inc.